2015
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
Cecchini M, Sznol M, Seropian S. Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant. Journal For ImmunoTherapy Of Cancer 2015, 3: 10. PMID: 25806109, PMCID: PMC4372324, DOI: 10.1186/s40425-015-0054-4.Peer-Reviewed Original ResearchAllogeneic stem cell transplantationStem cell transplantationMetastatic melanomaCell transplantationAllogeneic bone marrow transplantSafety of immunotherapyPost-transplant patientsBone marrow transplantHost diseaseTransplant patientsImmune therapyMarrow transplantTheoretical riskMelanomaImmunotherapyPatientsTransplantationTherapyGVHDTransplantGraftDisease
1998
Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant
Seropian S, Ferguson D, Salloum E, Cooper D, Landry M. Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplantation 1998, 22: 507-509. PMID: 9733277, DOI: 10.1038/sj.bmt.1701354.Peer-Reviewed Original ResearchConceptsPeripheral blood leukocytesAntigenemia testingCMV diseaseCMV infectionAntiviral therapyBlood leukocytesPre-emptive antiviral therapyAllogeneic bone marrow transplantationAllogeneic bone marrow transplantAntibody poolEarly detectionCMV pp65 antigenemiaBone marrow transplantationBone marrow transplantPeripheral blood specimensPeripheral blood samplesAllogeneic BMTLiver transaminasesPp65 antigenemiaAbnormal transaminasesMarrow transplantationMarrow transplantViral cultureAplastic anemiaBronchial lavage